vs
Side-by-side financial comparison of ROCKWELL MEDICAL, INC. (RMTI) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $17.3M, roughly 1.8× ROCKWELL MEDICAL, INC.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -9.2%, a 8.9% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -8.5%). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -18.2%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
RMTI vs SAMG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $32.0M |
| Net Profit | $-1.6M | $-120.0K |
| Gross Margin | 16.8% | — |
| Operating Margin | — | -2.8% |
| Net Margin | -9.2% | -0.4% |
| Revenue YoY | -8.5% | -0.0% |
| Net Profit YoY | — | -107.4% |
| EPS (diluted) | $-0.04 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $17.3M | — | ||
| Q4 25 | $18.3M | $32.0M | ||
| Q3 25 | $15.9M | $31.3M | ||
| Q2 25 | $16.1M | $30.7M | ||
| Q1 25 | $18.9M | $31.4M | ||
| Q4 24 | $24.7M | $32.0M | ||
| Q3 24 | $28.3M | $30.4M | ||
| Q2 24 | $25.8M | $31.0M |
| Q1 26 | $-1.6M | — | ||
| Q4 25 | $-554.0K | $-120.0K | ||
| Q3 25 | $-1.8M | $618.0K | ||
| Q2 25 | $-1.5M | $1.9M | ||
| Q1 25 | $-1.5M | $2.5M | ||
| Q4 24 | $-756.0K | $1.6M | ||
| Q3 24 | $1.7M | $2.3M | ||
| Q2 24 | $343.0K | $2.7M |
| Q1 26 | 16.8% | — | ||
| Q4 25 | 21.1% | — | ||
| Q3 25 | 14.3% | — | ||
| Q2 25 | 15.6% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 22.0% | — | ||
| Q2 24 | 17.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.2% | -2.8% | ||
| Q3 25 | -9.9% | 4.3% | ||
| Q2 25 | -8.4% | 13.2% | ||
| Q1 25 | -7.2% | 15.4% | ||
| Q4 24 | -2.1% | 6.1% | ||
| Q3 24 | 6.8% | 14.6% | ||
| Q2 24 | 2.0% | 17.1% |
| Q1 26 | -9.2% | — | ||
| Q4 25 | -3.0% | -0.4% | ||
| Q3 25 | -11.0% | 2.0% | ||
| Q2 25 | -9.3% | 6.3% | ||
| Q1 25 | -8.0% | 7.9% | ||
| Q4 24 | -3.1% | 5.1% | ||
| Q3 24 | 5.9% | 7.4% | ||
| Q2 24 | 1.3% | 8.6% |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $-0.01 | $0.02 | ||
| Q3 25 | $-0.05 | $0.07 | ||
| Q2 25 | $-0.05 | $0.21 | ||
| Q1 25 | $-0.04 | $0.26 | ||
| Q4 24 | $-0.02 | $0.16 | ||
| Q3 24 | $0.04 | $0.24 | ||
| Q2 24 | $0.01 | $0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.9M | $50.3M |
| Total Assets | $57.4M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.7M | $44.1M | ||
| Q3 25 | $13.6M | $36.1M | ||
| Q2 25 | $12.5M | $30.0M | ||
| Q1 25 | $11.4M | $36.3M | ||
| Q4 24 | $15.7M | $68.6M | ||
| Q3 24 | $12.3M | $58.1M | ||
| Q2 24 | $11.9M | $49.9M |
| Q1 26 | $35.9M | — | ||
| Q4 25 | $37.0M | $50.3M | ||
| Q3 25 | $37.0M | $58.9M | ||
| Q2 25 | $30.4M | $64.6M | ||
| Q1 25 | $31.5M | $80.0M | ||
| Q4 24 | $32.6M | $80.7M | ||
| Q3 24 | $29.1M | $84.6M | ||
| Q2 24 | $23.5M | $85.3M |
| Q1 26 | $57.4M | — | ||
| Q4 25 | $57.1M | $166.6M | ||
| Q3 25 | $57.5M | $157.6M | ||
| Q2 25 | $52.6M | $152.7M | ||
| Q1 25 | $54.0M | $159.9M | ||
| Q4 24 | $59.2M | $194.4M | ||
| Q3 24 | $57.1M | $184.2M | ||
| Q2 24 | $53.0M | $177.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.6M |
| Free Cash FlowOCF − Capex | — | $15.0M |
| FCF MarginFCF / Revenue | — | 46.9% |
| Capex IntensityCapex / Revenue | — | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.3M | $18.6M | ||
| Q3 25 | $-1.3M | $14.6M | ||
| Q2 25 | $1.8M | $13.8M | ||
| Q1 25 | $-3.5M | $-24.7M | ||
| Q4 24 | $865.0K | $21.6M | ||
| Q3 24 | $4.3M | $13.3M | ||
| Q2 24 | $1.4M | $16.0M |
| Q1 26 | — | — | ||
| Q4 25 | $2.2M | $15.0M | ||
| Q3 25 | $-1.5M | $13.8M | ||
| Q2 25 | $1.7M | $13.4M | ||
| Q1 25 | $-3.5M | $-25.1M | ||
| Q4 24 | $470.0K | $19.9M | ||
| Q3 24 | $4.1M | $12.9M | ||
| Q2 24 | $1.2M | $15.6M |
| Q1 26 | — | — | ||
| Q4 25 | 12.0% | 46.9% | ||
| Q3 25 | -9.6% | 44.1% | ||
| Q2 25 | 10.5% | 43.6% | ||
| Q1 25 | -18.8% | -80.0% | ||
| Q4 24 | 1.9% | 62.2% | ||
| Q3 24 | 14.4% | 42.4% | ||
| Q2 24 | 4.5% | 50.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 11.4% | ||
| Q3 25 | 1.4% | 2.6% | ||
| Q2 25 | 1.0% | 1.5% | ||
| Q1 25 | 0.3% | 1.3% | ||
| Q4 24 | 1.6% | 5.3% | ||
| Q3 24 | 0.7% | 1.2% | ||
| Q2 24 | 1.1% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | 2.57× | 5.90× | ||
| Q2 24 | 4.20× | 6.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RMTI
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
